Regeneron says COVID antibody treatment protects for at least 8 months
A synthetic antibody treatment developed by Regeneron reduced the risk of developing symptomatic COVID by more than 80 percent up to eight months after receiving the treatment, the US biotech firm said Monday.
Nov 8, 2021
0
9